Your browser doesn't support javascript.
loading
Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.
Koyama, Shingo; Sekijima, Yoshiki; Ogura, Masatsune; Hori, Mika; Matsuki, Kota; Miida, Takashi; Harada-Shiba, Mariko.
Affiliation
  • Koyama S; Division of Neurology and Clinical Neuroscience, Department of Internal Medicine III, Yamagata University Faculty of Medicine.
  • Sekijima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine.
  • Ogura M; Institute for Biomedical Sciences, Shinshu University.
  • Hori M; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
  • Matsuki K; Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University.
  • Miida T; Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine.
  • Harada-Shiba M; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine.
J Atheroscler Thromb ; 28(9): 905-925, 2021 Sep 01.
Article in En | MEDLINE | ID: mdl-33967188

Full text: 1 Database: MEDLINE Main subject: Xanthomatosis, Cerebrotendinous Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Atheroscler Thromb Journal subject: ANGIOLOGIA Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Xanthomatosis, Cerebrotendinous Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Atheroscler Thromb Journal subject: ANGIOLOGIA Year: 2021 Type: Article